Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2024 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Strengthened financial position resulting from recently announced MARGENZA® transaction and previously announced receipt of milestone payment from Incyte related to advancement of ZYNYZ®ADAM9-directed...
April 10, 2021 08:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Presentations at the 2021 AACR Annual Meeting

ROCKVILLE, MD, April 10, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...